<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR15">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kumar</surname>
    <given-names>SK</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma</article-title>
  <source>Blood</source>
  <year>2014</year>
  <volume>124</volume>
  <fpage>1047</fpage>
  <lpage>1055</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2014-01-548941</pub-id>
  <?supplied-pmid 24904120?>
  <pub-id pub-id-type="pmid">24904120</pub-id>
 </element-citation>
</ref>
